Home Cart Sign in  
Chemical Structure| 16816-67-4 Chemical Structure| 16816-67-4

Structure of Pantethine
CAS No.: 16816-67-4

Chemical Structure| 16816-67-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pantethine is a naturally occurring compound synthesized in the body from vitamin B5 via addition of cysteamine.

Synonyms: D-Pantethine; LBF disulfide; Lipodel

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pantethine

CAS No. :16816-67-4
Formula : C22H42N4O8S2
M.W : 554.72
SMILES Code : O=C(CCNC([C@@H](C(C)(CO)C)O)=O)NCCSSCCNC(CCNC([C@@H](C(C)(CO)C)O)=O)=O
Synonyms :
D-Pantethine; LBF disulfide; Lipodel
MDL No. :MFCD07357234
InChI Key :DJWYOLJPSHDSAL-ROUUACIJSA-N
Pubchem ID :452306

Safety of Pantethine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H315-H318-H335-H411
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P362+P364-P403+P233-P501
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MCA205 cells 1 mM 4 hours To evaluate the effect of Pantethine on mitochondrial reactive oxygen species (mtROS) production, results showed Pantethine slightly enhanced mtROS generation. Life Sci Alliance. 2023 Oct 13;6(12):e202302200
Calu-3a cells 50-1000 µM 48 hours To evaluate the antiviral effect of pantethine against SARS-CoV-2 infection in Calu-3a cells. Results showed that pantethine significantly reduced viral S and N protein expression and viral RNA copy numbers. Sci Rep. 2023 Feb 8;13(1):2237
HEK293 cells 100 µM 48 hours Pantethine improved mitochondrial function in hPANK2-depleted cells. Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6988-93
Human Th1 and Th17 cells 1.0 mM 5 days PTTH significantly reduced the production of pro-inflammatory cytokines (e.g., IFN-γ and GM-CSF) by human Th1 and Th17 cells. J Neuroinflammation. 2024 Nov 5;21(1):287
PLP139-151-specific T cells 1.0 mM 6-12 hours PTTH restored the CoA synthesis pathway, reshaped the metabolic profile of proliferating autoreactive T cells, and significantly reduced their pro-inflammatory cytokine production. J Neuroinflammation. 2024 Nov 5;21(1):287
Drosophila Schneider’s S2 cells 100 µM 7 days Pantethine restored CoA levels and improved mitochondrial function in dPANK/Fbl-depleted cells. Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6988-93
Vero E6 cells 50-1000 µM 72 hours To evaluate the antiviral effect of pantethine against SARS-CoV-2 infection. Results showed that pantethine significantly reduced the infection rate of Vero E6 cells, decreased viral S and N protein expression, and reduced viral RNA copy numbers. Sci Rep. 2023 Feb 8;13(1):2237

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice MCA205 sarcoma model Intraperitoneal injection 1 g/Kg Daily starting from day 10 post cell engraftment To evaluate the inhibitory effect of Pantethine on sarcoma growth and its impact on immune responses, results showed Pantethine significantly inhibited sarcoma growth in immunocompetent mice but not in nude mice, indicating its dependence on the immune system. Life Sci Alliance. 2023 Oct 13;6(12):e202302200
Drosophila melanogaster DPANK/fbl mutants Oral 1.6 mg/mL Continuous feeding Pantethine restored CoA levels, improved mitochondrial function, reduced oxidative damage, enhanced locomotor abilities, rescued brain degeneration, and increased lifespan in dPANK/fbl mutants. Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6988-93
5XFAD transgenic mice Alzheimer’s disease model Intraperitoneal injection 15 mg Three times a week for 5.5 months Long-term pantethine treatment significantly reduced glial reactivity and Aβ deposition, and abrogated behavioral alteration in Tg mice. Moreover, transcriptomic analysis revealed that after pantethine treatment, the expression of genes differentially expressed in Tg mice, particularly those related to AD, was significantly alleviated. Neurotherapeutics. 2019 Oct;16(4):1237-1254
Mice Pank2/C0//C0 mouse model Drinking water 15 mg/kg/day Continuous administration for 2 months To evaluate the preventive effect of Pantethine on ketogenic diet-induced PKAN-like symptoms. Results showed that Pantethine prevented the onset of neuromuscular phenotype, improved motor dysfunction, extended survival, and ameliorated mitochondrial morphology and function. Brain. 2014 Jan;137(Pt 1):57-68
SJL and C57Bl/6 mice Experimental autoimmune encephalomyelitis (EAE) Intraperitoneally (i.p.) 30 mg/mouse/day Daily for 20 consecutive days PTTH significantly inhibited EAE development in both pre-clinical and therapeutic settings, reducing disease severity and inflammatory infiltrates. J Neuroinflammation. 2024 Nov 5;21(1):287
SCID female mice Orthotopic model of ovarian cancer Intraperitoneal injection 750 mg/kg Daily for 4 weeks To evaluate the effect of Pantethine on ovarian tumor growth, metastasis, and ascites formation. Results showed that Pantethine treatment significantly slowed tumor progression, decreased levels of phosphocholine and phosphatidylcholine, and reduced metastases and ascites occurrence. Front Oncol. 2016 Nov 16;6:244

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.80mL

0.36mL

0.18mL

9.01mL

1.80mL

0.90mL

18.03mL

3.61mL

1.80mL

References

 

Historical Records

Categories